Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 3.02 Million USD | 1197.21% |
| 2023 | 233.51 Thousand USD | -90.24% |
| 2022 | 2.39 Million USD | 492.55% |
| 2021 | -609.65 Thousand USD | -409.06% |
| 2020 | -119.76 Thousand USD | 94.73% |
| 2019 | -2.27 Million USD | -499.68% |
| 2018 | -379.17 Thousand USD | -338.61% |
| 2017 | -86.45 Thousand USD | -743.66% |
| 2016 | -10.24 Thousand USD | 95.75% |
| 2015 | -241.05 Thousand USD | -19.11% |
| 2014 | -202.38 Thousand USD | 80.44% |
| 2013 | -1.03 Million USD | -992.8% |
| 2012 | -94.67 Thousand USD | -112.44% |
| 2011 | 761.27 Thousand USD | 149.77% |
| 2010 | 304.79 Thousand USD | 283.33% |
| 2009 | 79.51 Thousand USD | 109.08% |
| 2008 | -875.68 Thousand USD | -4.23% |
| 2007 | -840.17 Thousand USD | 58.62% |
| 2006 | -2.03 Million USD | 6.5% |
| 2005 | -2.17 Million USD | -532.67% |
| 2004 | -343.26 Thousand USD | 90.19% |
| 2003 | -3.49 Million USD | 39.4% |
| 2002 | -5.77 Million USD | 44.53% |
| 2001 | -10.4 Million USD | 30.34% |
| 2000 | -14.94 Million USD | -7372.32% |
| 1999 | -200 Thousand USD | 88.89% |
| 1998 | -1.8 Million USD | 10.0% |
| 1997 | -2 Million USD | 13.04% |
| 1996 | -2.3 Million USD | 4.17% |
| 1995 | -2.4 Million USD | -50.0% |
| 1994 | -1.6 Million USD | 33.33% |
| 1993 | -2.4 Million USD | 36.84% |
| 1992 | -3.8 Million USD | -322.22% |
| 1991 | -900 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.6 Million USD | 588.89% |
| 2024 Q3 | 2.09 Million USD | 15.48% |
| 2024 Q2 | 1.81 Million USD | 12.6% |
| 2024 Q4 | 3.02 Million USD | 44.82% |
| 2023 Q2 | 2.33 Million USD | 6.89% |
| 2023 Q1 | 2.18 Million USD | -8.72% |
| 2023 FY | 233.51 Thousand USD | -90.24% |
| 2023 Q3 | 1.96 Million USD | -15.97% |
| 2023 Q4 | 233.51 Thousand USD | -88.1% |
| 2022 Q3 | 1.89 Million USD | 30.26% |
| 2022 FY | 2.39 Million USD | 492.55% |
| 2022 Q1 | -1.44 Million USD | -136.52% |
| 2022 Q2 | 1.45 Million USD | 200.73% |
| 2022 Q4 | 2.39 Million USD | 26.49% |
| 2021 Q3 | -506.06 Thousand USD | -493.85% |
| 2021 Q4 | -609.65 Thousand USD | -20.47% |
| 2021 FY | -609.65 Thousand USD | -409.06% |
| 2021 Q1 | 79.46 Thousand USD | 166.35% |
| 2021 Q2 | 128.49 Thousand USD | 61.7% |
| 2020 FY | -119.76 Thousand USD | 94.73% |
| 2020 Q1 | -678.17 Thousand USD | 70.17% |
| 2020 Q2 | -192.53 Thousand USD | 71.61% |
| 2020 Q3 | -391.69 Thousand USD | -103.44% |
| 2020 Q4 | -119.76 Thousand USD | 69.42% |
| 2019 FY | -2.27 Million USD | -499.68% |
| 2019 Q4 | -2.27 Million USD | -70.21% |
| 2019 Q1 | -329.93 Thousand USD | 12.99% |
| 2019 Q2 | -1.72 Million USD | -422.98% |
| 2019 Q3 | -1.33 Million USD | 22.58% |
| 2018 Q4 | -379.17 Thousand USD | -115.22% |
| 2018 FY | -379.17 Thousand USD | -338.61% |
| 2018 Q1 | -164.8 Thousand USD | -90.64% |
| 2018 Q2 | -353.92 Thousand USD | -114.75% |
| 2018 Q3 | -176.18 Thousand USD | 50.22% |
| 2017 Q3 | -124.62 Thousand USD | 74.07% |
| 2017 Q2 | -480.63 Thousand USD | -192.16% |
| 2017 FY | -86.45 Thousand USD | -743.66% |
| 2017 Q1 | -164.51 Thousand USD | -1505.45% |
| 2017 Q4 | -86.45 Thousand USD | 30.63% |
| 2016 Q3 | -130.57 Thousand USD | 68.22% |
| 2016 Q1 | -111.71 Thousand USD | 53.65% |
| 2016 Q4 | -10.24 Thousand USD | 92.15% |
| 2016 FY | -10.24 Thousand USD | 95.75% |
| 2016 Q2 | -410.89 Thousand USD | -267.79% |
| 2015 Q1 | -527.49 Thousand USD | -160.64% |
| 2015 Q4 | -241.05 Thousand USD | 14.91% |
| 2015 Q3 | -283.27 Thousand USD | 26.45% |
| 2015 FY | -241.05 Thousand USD | -19.11% |
| 2015 Q2 | -385.16 Thousand USD | 26.98% |
| 2014 Q3 | -364.86 Thousand USD | 36.83% |
| 2014 Q4 | -202.38 Thousand USD | 44.53% |
| 2014 FY | -202.38 Thousand USD | 80.44% |
| 2014 Q2 | -577.58 Thousand USD | 34.29% |
| 2014 Q1 | -879.03 Thousand USD | 15.04% |
| 2013 Q2 | -1.63 Million USD | 30.04% |
| 2013 FY | -1.03 Million USD | -992.8% |
| 2013 Q4 | -1.03 Million USD | 19.07% |
| 2013 Q3 | -1.27 Million USD | 21.83% |
| 2013 Q1 | -2.33 Million USD | -2369.23% |
| 2012 Q1 | -992.64 Thousand USD | -230.39% |
| 2012 Q3 | -367.4 Thousand USD | 48.91% |
| 2012 Q2 | -719.15 Thousand USD | 27.55% |
| 2012 FY | -94.67 Thousand USD | -112.44% |
| 2012 Q4 | -94.67 Thousand USD | 74.23% |
| 2011 FY | 761.27 Thousand USD | 149.77% |
| 2011 Q2 | 651.24 Thousand USD | 38.73% |
| 2011 Q1 | 469.42 Thousand USD | 54.01% |
| 2011 Q3 | 726.26 Thousand USD | 11.52% |
| 2011 Q4 | 761.27 Thousand USD | 4.82% |
| 2010 Q3 | 348.48 Thousand USD | -7.64% |
| 2010 FY | 304.79 Thousand USD | 283.33% |
| 2010 Q4 | 304.79 Thousand USD | -12.54% |
| 2010 Q2 | 377.29 Thousand USD | 106.95% |
| 2010 Q1 | 182.3 Thousand USD | 129.29% |
| 2009 Q4 | 79.51 Thousand USD | 172.12% |
| 2009 FY | 79.51 Thousand USD | 109.08% |
| 2009 Q2 | -4770.00 USD | 98.91% |
| 2009 Q3 | -110.24 Thousand USD | -2211.24% |
| 2009 Q1 | -438.91 Thousand USD | 49.88% |
| 2008 Q2 | -306.69 Thousand USD | 43.18% |
| 2008 Q3 | -234.56 Thousand USD | 23.52% |
| 2008 Q4 | -875.68 Thousand USD | -273.33% |
| 2008 Q1 | -539.72 Thousand USD | 35.76% |
| 2008 FY | -875.68 Thousand USD | -4.23% |
| 2007 Q3 | -2.11 Million USD | -282.26% |
| 2007 Q4 | -840.17 Thousand USD | 60.2% |
| 2007 FY | -840.17 Thousand USD | 58.62% |
| 2007 Q1 | -1.27 Million USD | 37.21% |
| 2007 Q2 | -552.29 Thousand USD | 56.68% |
| 2006 Q4 | -2.03 Million USD | -311.84% |
| 2006 Q2 | -909.45 Thousand USD | 44.28% |
| 2006 Q1 | -1.63 Million USD | 24.84% |
| 2006 FY | -2.03 Million USD | 6.5% |
| 2006 Q3 | -493.01 Thousand USD | 45.79% |
| 2005 FY | -2.17 Million USD | -532.67% |
| 2005 Q1 | -4.73 Million USD | -1278.98% |
| 2005 Q3 | -3.03 Million USD | 22.05% |
| 2005 Q4 | -2.17 Million USD | 28.51% |
| 2005 Q2 | -3.89 Million USD | 17.67% |
| 2004 Q1 | -2.74 Million USD | 21.41% |
| 2004 FY | -343.26 Thousand USD | 90.19% |
| 2004 Q4 | -343.26 Thousand USD | 63.7% |
| 2004 Q3 | -945.65 Thousand USD | 45.22% |
| 2004 Q2 | -1.72 Million USD | 37.23% |
| 2003 FY | -3.49 Million USD | 39.4% |
| 2003 Q4 | -3.49 Million USD | 7.35% |
| 2003 Q3 | -3.77 Million USD | 17.39% |
| 2003 Q2 | -4.57 Million USD | 9.65% |
| 2003 Q1 | -5.05 Million USD | 12.37% |
| 2002 FY | -5.77 Million USD | 44.53% |
| 2002 Q4 | -5.77 Million USD | 13.32% |
| 2002 Q3 | -6.66 Million USD | 12.96% |
| 2002 Q2 | -7.65 Million USD | 14.58% |
| 2002 Q1 | -8.95 Million USD | 13.93% |
| 2001 Q2 | -15.38 Million USD | 8.38% |
| 2001 Q4 | -10.4 Million USD | 12.67% |
| 2001 FY | -10.4 Million USD | 30.34% |
| 2001 Q1 | -16.79 Million USD | -12.39% |
| 2001 Q3 | -11.92 Million USD | 22.54% |
| 2000 Q2 | -1.3 Million USD | -85.71% |
| 2000 FY | -14.94 Million USD | -7372.32% |
| 2000 Q3 | -16.48 Million USD | -1167.78% |
| 2000 Q1 | -700 Thousand USD | -250.0% |
| 2000 Q4 | -14.94 Million USD | 9.32% |
| 1999 Q4 | -200 Thousand USD | 33.33% |
| 1999 FY | -200 Thousand USD | 88.89% |
| 1999 Q1 | -1.1 Million USD | 38.89% |
| 1999 Q2 | -500 Thousand USD | 54.55% |
| 1999 Q3 | -300 Thousand USD | 40.0% |
| 1998 Q1 | -1.6 Million USD | 20.0% |
| 1998 Q4 | -1.8 Million USD | -100.0% |
| 1998 Q3 | -900 Thousand USD | 18.18% |
| 1998 Q2 | -1.1 Million USD | 31.25% |
| 1998 FY | -1.8 Million USD | 10.0% |
| 1997 Q2 | -1.9 Million USD | 5.0% |
| 1997 Q4 | -2 Million USD | -5.26% |
| 1997 FY | -2 Million USD | 13.04% |
| 1997 Q1 | -2 Million USD | 13.04% |
| 1997 Q3 | -1.9 Million USD | 0.0% |
| 1996 FY | -2.3 Million USD | 4.17% |
| 1996 Q3 | -1.9 Million USD | 26.92% |
| 1996 Q1 | -2.5 Million USD | -4.17% |
| 1996 Q2 | -2.6 Million USD | -4.0% |
| 1996 Q4 | -2.3 Million USD | -21.05% |
| 1995 Q3 | -2.1 Million USD | -10.53% |
| 1995 Q4 | -2.4 Million USD | -14.29% |
| 1995 Q2 | -1.9 Million USD | -5.56% |
| 1995 Q1 | -1.8 Million USD | -12.5% |
| 1995 FY | -2.4 Million USD | -50.0% |
| 1994 Q2 | -1.5 Million USD | 11.76% |
| 1994 Q3 | -1.4 Million USD | 6.67% |
| 1994 Q4 | -1.6 Million USD | -14.29% |
| 1994 FY | -1.6 Million USD | 33.33% |
| 1994 Q1 | -1.7 Million USD | 29.17% |
| 1993 Q3 | -2.5 Million USD | 10.71% |
| 1993 Q2 | -2.8 Million USD | 12.5% |
| 1993 Q1 | -3.2 Million USD | 15.79% |
| 1993 FY | -2.4 Million USD | 36.84% |
| 1993 Q4 | -2.4 Million USD | 4.0% |
| 1992 FY | -3.8 Million USD | -322.22% |
| 1992 Q4 | -3.8 Million USD | 0.0% |
| 1991 FY | -900 Thousand USD | 0.0% |
| 1991 Q4 | -900 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -17.365% |
| AngioDynamics, Inc. | -70.14 Million USD | 104.319% |
| AtriCure, Inc. | -9.81 Million USD | 130.86% |
| Avinger, Inc. | 10.12 Million USD | 70.067% |
| Azenta, Inc. | -618.47 Million USD | 100.49% |
| BioLife Solutions, Inc. | 7.25 Million USD | 58.235% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 99.876% |
| Daxor Corporation | 755.65 Thousand USD | -300.866% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 306.067% |
| Femasys Inc. | -15.01 Million USD | 120.174% |
| GlucoTrack, Inc. | -4.29 Million USD | 170.512% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 92.13% |
| Hologic, Inc. | 374.4 Million USD | 99.191% |
| ICU Medical, Inc. | 1.45 Billion USD | 99.791% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 100.114% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 143.046% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 158.546% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 170.652% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 170.652% |
| Masimo Corporation | 804 Million USD | 99.623% |
| Microbot Medical Inc. | -2.28 Million USD | 232.51% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 131.568% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 98.998% |
| Nephros, Inc. | -2.47 Million USD | 222.589% |
| NovoCure Limited | 355.42 Million USD | 99.148% |
| NEXGEL, Inc. | 98 Thousand USD | -2991.003% |
| NEXGEL, Inc. | 98 Thousand USD | -2991.003% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 94.871% |
| OraSure Technologies, Inc. | -276.9 Million USD | 101.094% |
| Pro-Dex, Inc. | 10.91 Million USD | 72.25% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 108.601% |
| Predictive Oncology Inc. | -5.87 Million USD | 151.588% |
| QuidelOrtho Corporation | 2.49 Billion USD | 99.879% |
| Repligen Corporation | -39.51 Million USD | 107.665% |
| Sanara MedTech Inc. | 6.64 Million USD | 54.413% |
| STAAR Surgical Company | -147.2 Million USD | 102.058% |
| Sharps Technology, Inc. | -3.01 Million USD | 200.54% |
| Utah Medical Products, Inc. | -92.52 Million USD | 103.274% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 99.846% |
| Jin Medical International Ltd. | -2.81 Million USD | 207.551% |